CNC Investors Have Opportunity to Join Centene Corporation Fraud Investigation with the Schall Law Firm
Werte in diesem Artikel
LOS ANGELES, July 15, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Centene is the subject of a Seeking Alpha report published on July 2, 2025. According to the report, the Company's shares "traded lower on Wednesday after the company withdrew its 2025 earnings guidance, citing a higher-than-anticipated cost trend attributed to its Medicaid enrollees and an unexpected underperformance in its Affordable Care Act plans business." The Company claimed that its "Medicaid business has experienced a step-up in medical cost trend in the same areas previously identified by the Company: behavioral health, home health, and high-cost drugs." Based on this news, shares of Centene fell by more than 39.5% in intraday trading on the same day.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
View original content to download multimedia:https://www.prnewswire.com/news-releases/cnc-investors-have-opportunity-to-join-centene-corporation-fraud-investigation-with-the-schall-law-firm-302504996.html
SOURCE The Schall Law Firm
Übrigens: Centene und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Centene
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Centene
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu Centene Corp.
Analysen zu Centene Corp.
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.10.2017 | Centene Outperform | BMO Capital Markets | |
| 05.04.2017 | Centene Buy | Deutsche Bank AG | |
| 08.02.2017 | Centene Overweight | Barclays Capital | |
| 07.02.2017 | Centene Overweight | Cantor Fitzgerald | |
| 20.06.2016 | Centene Overweight | Barclays Capital |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.10.2017 | Centene Outperform | BMO Capital Markets | |
| 05.04.2017 | Centene Buy | Deutsche Bank AG | |
| 08.02.2017 | Centene Overweight | Barclays Capital | |
| 07.02.2017 | Centene Overweight | Cantor Fitzgerald | |
| 20.06.2016 | Centene Overweight | Barclays Capital |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.06.2015 | Centene Hold | Deutsche Bank AG | |
| 15.06.2015 | Centene Mkt Perform | FBR Capital | |
| 28.04.2015 | Centene Mkt Perform | FBR Capital | |
| 11.02.2015 | Centene Neutral | UBS AG | |
| 15.12.2014 | Centene Hold | Deutsche Bank AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.12.2006 | Update Centene Corp.: Sell | Goldman Sachs | |
| 12.06.2006 | Update Centene Corp.: Sell | Matrix Research |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Centene Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen